We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
-5.32%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$167M
AUM Growth
-$394M
Cap. Flow
-$366M
Cap. Flow %
-218.91%
Top 10 Hldgs %
44.66%
Holding
98
New
19
Increased
–
Reduced
39
Closed
38

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$4.56M
2
WBA
Walgreens Boots Alliance
WBA
+$2.89M
3
AGN
Allergan plc
AGN
+$2.59M
4
AAAP
Advanced Accelerator Applications S.A.
AAAP
+$2.02M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.9M

Top Sells

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$20.2M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$17M
3
PFE icon
Pfizer
PFE
+$16.9M
4
ZBH icon
Zimmer Biomet
ZBH
+$13.2M
5
SHPG
Shire pic
SHPG
+$12.6M

Sector Composition

Rank Sector Weight
1 Healthcare 75.65%
2 Energy 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
76
Pacira BioSciences
PCRX
$925M
– –
-150,000
Closed -$5.13M
PFE icon
77
Pfizer
PFE
$152B
– –
-527,000
Closed -$16.9M
SRPT icon
78
Sarepta Therapeutics
SRPT
$1.94B
– –
-50,000
Closed -$3.07M
THC icon
79
Tenet Healthcare
THC
$21.5B
– –
-100,000
Closed -$2.27M
TVTX icon
80
Travere Therapeutics
TVTX
$5.78B
– –
-200,000
Closed -$4.48M
ISEE
81
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-70,000
Closed -$3.23M
AERI
82
PUT
DELISTED
Aerie Pharmaceuticals
AERI
– –
-130,000
Closed -$4.91M
GBT
83
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-100,000
Closed -$5.25M
EPZM
84
DELISTED
Epizyme, Inc
EPZM
– –
-150,000
Closed -$1.48M
PRAH
85
DELISTED
PRA Health Sciences, Inc.
PRAH
– –
-30,000
Closed -$1.7M
GWPH
86
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-50,000
Closed -$6.64M
GWPH
87
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-40,000
Closed -$5.31M
GWPH
88
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-130,000
Closed -$17.3M
FPRX
89
PUT
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-50,000
Closed -$2.61M
ONCE
90
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-25,000
Closed -$1.5M
IVTY
91
DELISTED
Invuity, Inc
IVTY
– –
-200,000
Closed -$2.74M
IPXL
92
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-200,000
Closed -$4.74M
PMC
93
DELISTED
PharMerica Corporation
PMC
– –
-150,000
Closed -$4.21M
PMC
94
PUT
DELISTED
PharMerica Corporation
PMC
– –
-100,000
Closed -$2.81M
KITE
95
DELISTED
Kite Pharma, Inc.
KITE
– –
-60,000
Closed -$3.35M
CELG
96
CALL
DELISTED
Celgene Corp
CELG
– –
-150,000
Closed -$15.7M
OMED
97
PUT
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
– –
-50,000
Closed -$572K
SHPG
98
DELISTED
Shire pic
SHPG
– –
-65,000
Closed -$12.6M
1 2 3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q4 2016 Portfolio in Review

As of Q4 2016, Iguana Healthcare Management held 98 positions worth $167M, down 70% from $561M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Iguana Healthcare Management withdrew a net $366M in Q4 2016, closing 38 positions and reducing 39 holdings. Its most notable exit was Pfizer, an estimated $16.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 73% a quarter earlier, followed by Energy.

Against the trend, Iguana Healthcare Management opened a new position in Abbott worth $4.42M.

  • Iguana Healthcare Management's largest Q4 2016 buy was Abbott: 115,000 shares worth $4.42M.
  • Iguana Healthcare Management's biggest Q4 2016 reduction was Clovis Oncology, Inc., cutting an estimated $20.2M.
  • Iguana Healthcare Management fully exited Pfizer in Q4 2016, selling an estimated $16.9M.
  • Iguana Healthcare Management's ten largest holdings make up 45% of its $167M portfolio in Q4 2016.
  • Iguana Healthcare Management opened 19 new positions and closed 38 in Q4 2016.
  • Iguana Healthcare Management's portfolio value fell 70% quarter-over-quarter to $167M.

Based on Iguana Healthcare Management's 13F filing for Q4 2016, filed 14 Feb 2017.